Drug resistance and cancer.
Morrow
C S
CS
Medicine Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
Cowan
K
K
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000145:classification / Q000493:pharmacokinetics / Q000627:therapeutic use; D001711:Biotransformation; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology; D004351:Drug Resistance / Q000235:genetics; D004798:Enzymes / Q000378:metabolism; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D004798:Enzymes; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors